Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Bristol-Myers Squibb Company
BMYHealth technology
$103.1B
Market Cap
Shariah Analysis
Failed
Business
Cash
Liabilities
Based on AAOIFI screening standards, Bristol-Myers Squibb Company appears to be Failed.
Business Activity
FYE 2024
Non-Permissible Income (<5%)0.00%
Non-Permissible
-
Total Income
$50.6K
Revenue Breakdown
Net product sales
$46.8K
Alliance and other revenues
$1.5K
Royalty income - divestitures
Non-Operating
$1.1K
Royalty and licensing income
Non-Operating
$736
Investment income
Non-Operating
$478
Equity investment gains
Non-Operating
$16
Financial Screening
FYE 2024
Cash (<30%)10.35%
Non-Shariah Cash Items
Cash And Cash Equivalents$10.3B
Other Short Term Investments$513M
Restricted Cash-
Held To Maturity Securities$452M
Liabilities (<30%)46.83%
Non-Shariah Liabilities
Current Capital Lease Obligation$181M
Long Term Debt$47.6B
Long Term Capital Lease Obligation$1.4B
Current Debt$2B
Market Data
Exchange
NYSE
CurrencyUSD
CountryUnited States
Last Updated2026-01-09
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
NYSE
